Company intelligence / Profile preview

Mayflower Bioscience

St. Louis, Missouri, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Mayflower Bioscience provides innovative research products for cell biology, molecular biology, drug discovery, infectious diseases, and COVID-19 testing, acting as a bridge for novel technologies (primarily from Europe) into the US market

Modalities: AntibodyReagentBioassayViral-based cell transfection solutionViral-based cell transduction solution
Industry: Drug Discovery Services

Partnerships

Cambridge Bioscience (UK life science distributor) – joined forces in October 2017 for broader support in North America and Europe

Beyond the preview

Go deeper on Mayflower Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mayflower Bioscience.

Explore the full profile